Update shared on 03 Nov 2025
Fair value Decreased 0.28%QBE Insurance Group's analyst price target has been slightly lowered from $23.29 to $23.22, as analysts cite modest adjustments to profit margin expectations and minor changes in growth forecasts.
What's in the News
- Chris Killourhy will be appointed as Group Chief Financial Officer, effective January 1, 2026, following an extensive career at QBE and in the insurance industry (Key Developments)
- Current CFO Inder Singh has resigned and will remain until a replacement is found to ensure a smooth transition (Key Developments)
- Dividend for the six months ending June 30, 2025, declared at AUD 0.31 per share with an ex-date on August 19, 2025 and payment on September 26, 2025 (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has decreased marginally from A$23.29 to A$23.22.
- Discount Rate remains unchanged at 6.48%.
- Revenue Growth projections are virtually flat, shifting from -3.58% to -3.58%.
- Net Profit Margin is expected to improve slightly, moving from 9.31% to 9.34%.
- Future P/E Ratio has risen slightly from 14.39x to 14.41x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.